Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

INOMAX DSIR Nitric Oxide delivery system Recalled by INO Therapeutics (dba Ikaria) Due to An issue has been identified in the INOmax...

Date: October 17, 2014
Company: INO Therapeutics (dba Ikaria)
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact INO Therapeutics (dba Ikaria) directly.

Affected Products

INOMAX DSIR Nitric Oxide delivery system, Model 10007, software version 3.1.0., delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and comprehensive alarm systems. The primary clinical settings are Neonatal Intensive Care Units (NICU) and to transport of neonates.

Quantity: 9

Why Was This Recalled?

An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.

Where Was This Sold?

This product was distributed to 2 states: PA, VA

Affected (2 states)Not affected

About INO Therapeutics (dba Ikaria)

INO Therapeutics (dba Ikaria) has 4 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report